Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Italian Journal of MedicineOpen Access

P149 | Acute and long-term management of venous thromboembolism through the post-COVID-19 pandemic era

View Full Paper
Ask AI
Bookmark
Share

Discussion

Loading...

Member takes

Overview

Observational analysis of VTE management reveals risks in patients with COVID-19, suggesting crucial adjustments in treatment plans.

Key Points

  • Patients with COVID-19 showed lower mortality rates compared to non-COVID-19 patients, highlighting differing risks.
  • After three months, fewer COVID-19 patients continued anticoagulant therapy, pointing to potential management challenges.
  • The initial therapy predominantly utilized low molecular weight heparin in VTE cases, indicating standard practices.
  • Major hemorrhagic events predominantly occurred within the first three months of therapy, suggesting critical early monitoring.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/68c23922b210217d6477a37bhttps://doi.org/10.4081/itjm.2025.2345
View Full Paper
Ask AI
Bookmark
Share